Neuraxpharm Arzneimittel GmbH

The latest meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use resulted in a raft of positive opinions for the off-patent industry. After eight denosumab nods in

Cosette Pharmaceuticals has named Brad Leonard as head of its generics business and Vincent Colicchio as chief of operations, as the New Jersey-based firm seeks to drive its “next phase of growth and

European central nervous system disorders specialist Neuraxpharm is continuing expansion in the therapeutic area after striking a deal to acquire the narcolepsy brands Provigil (modafinil) and Nuvigil

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Partners With UK’s Alchemab On A